Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

802 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mapping the planet's critical natural assets.
Chaplin-Kramer R, Neugarten RA, Sharp RP, Collins PM, Polasky S, Hole D, Schuster R, Strimas-Mackey M, Mulligan M, Brandon C, Diaz S, Fluet-Chouinard E, Gorenflo LJ, Johnson JA, Kennedy CM, Keys PW, Longley-Wood K, McIntyre PB, Noon M, Pascual U, Reidy Liermann C, Roehrdanz PR, Schmidt-Traub G, Shaw MR, Spalding M, Turner WR, van Soesbergen A, Watson RA. Chaplin-Kramer R, et al. Among authors: mulligan m. Nat Ecol Evol. 2023 Jan;7(1):51-61. doi: 10.1038/s41559-022-01934-5. Epub 2022 Nov 28. Nat Ecol Evol. 2023. PMID: 36443466 Free PMC article.
Mapping the planet's critical areas for biodiversity and nature's contributions to people.
Neugarten RA, Chaplin-Kramer R, Sharp RP, Schuster R, Strimas-Mackey M, Roehrdanz PR, Mulligan M, van Soesbergen A, Hole D, Kennedy CM, Oakleaf JR, Johnson JA, Kiesecker J, Polasky S, Hanson JO, Rodewald AD. Neugarten RA, et al. Among authors: mulligan m. Nat Commun. 2024 Jan 10;15(1):261. doi: 10.1038/s41467-023-43832-9. Nat Commun. 2024. PMID: 38199986 Free PMC article.
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen CP, Chen TC, Cheng SH, Cheng CY, Chung WS, Cohen YZ, Cowan LN, Dalgard O, de Almeida E Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang YW, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo CY, Le T, Lin YC, Lin WP, Lin TH, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O'Brien SM, Okeke NL, Perez L, Perez-Padilla R, Perrin L, Remigio-Luna A, Rivera-Martinez NE, Rockhold FW, Rodriguez-Llamazares S, Rolfe R, Rosa R, Røsjø H, Sampaio VS, Seto TB, Shahzad M, Soliman S, Stout JE, Thirion-Romero I, Troxel AB, Tseng TY, Turner NA, Ulrich RJ, Walsh SR, Webb SA, Weehuizen JM, Velinova M, Wong HL, Wrenn R, Zampieri FG, Zhong W, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG. Axfors C, et al. Among authors: mulligan mj. Nat Commun. 2024 Feb 5;15(1):1075. doi: 10.1038/s41467-024-45360-6. Nat Commun. 2024. PMID: 38316844 Free PMC article. No abstract available.
Atp1a2 and Kcnj9 are candidate genes underlying oxycodone behavioral sensitivity and withdrawal in C57BL/6 substrains.
Goldberg LR, Baskin BM, Adla Y, Beierle JA, Kelliher JC, Yao EJ, Kirkpatrick SL, Reed ER, Jenkins DF, Luong AM, Luttik KP, Scotellaro JA, Drescher TA, Crotts SB, Yazdani N, Ferris MT, Johnson WE, Mulligan MK, Bryant CD. Goldberg LR, et al. Among authors: mulligan mk. bioRxiv [Preprint]. 2024 Apr 17:2024.04.16.589731. doi: 10.1101/2024.04.16.589731. bioRxiv. 2024. PMID: 38798314 Free PMC article. Preprint.
Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York.
Gámbaro F, Duerr R, Dimartino D, Marier C, Iturrate E, Mulligan MJ, Heguy A, Dellicour S. Gámbaro F, et al. Among authors: mulligan mj. Virus Evol. 2024 May 7;10(1):veae035. doi: 10.1093/ve/veae035. eCollection 2024. Virus Evol. 2024. PMID: 38774310 Free PMC article.
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.
Kister I, Curtin R, Piquet AL, Borko T, Pei J, Banbury BL, Bacon TE, Kim A, Tuen M, Velmurugu Y, Nyovanie S, Selva S, Samanovic MI, Mulligan MJ, Patskovsky Y, Priest J, Cabatingan M, Winger RC, Krogsgaard M, Silverman GJ. Kister I, et al. Among authors: mulligan mj. Ann Clin Transl Neurol. 2024 May 7. doi: 10.1002/acn3.52081. Online ahead of print. Ann Clin Transl Neurol. 2024. PMID: 38713096 Free article.
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex.
Martínez JL, Lemus N, Lai TY, Mishra M, González-Domínguez I, Puente-Massaguer E, Loganathan M, Francis B, Samanovic MI, Krammer F, Mulligan MJ, Simon V, Palese P, Sun W. Martínez JL, et al. Among authors: mulligan mj. Vaccine. 2024 May 22;42(14):3365-3373. doi: 10.1016/j.vaccine.2024.04.037. Epub 2024 Apr 15. Vaccine. 2024. PMID: 38627145 Free article.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Happe M, Hofstetter AR, Wang J, Yamshchikov GV, Holman LA, Novik L, Strom L, Kiweewa F, Wakabi S, Millard M, Kelley CF, Kabbani S, Edupuganti S, Beck A, Kaltovich F, Murray T, Tsukerman S, Carr D, Ashman C, Stanley DA, Ploquin A, Bailer RT, Schwartz R, Cham F, Tindikahwa A, Hu Z, Gordon IJ, Rouphael N, Houser KV, Coates EE, Graham BS, Koup RA, Mascola JR, Sullivan NJ, Robb ML, Ake JA, Lyke KE, Mulligan MJ, Ledgerwood JE, Kibuuka H; VRC 208 and RV 422 study team. Happe M, et al. Among authors: mulligan mj. NPJ Vaccines. 2024 Mar 29;9(1):67. doi: 10.1038/s41541-024-00833-z. NPJ Vaccines. 2024. PMID: 38553525 Free PMC article.
802 results